Canada markets close in 2 hours 21 minutes

Algernon Pharmaceuticals Inc. (AGN.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.1550-0.0100 (-6.06%)
As of 12:52PM EDT. Market open.
Currency in CAD

Valuation Measures

Market Cap (intraday) 521.73M
Enterprise Value 320.05M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.42
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 7N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-51.47%
S&P500 52-Week Change 345.93%
52 Week High 30.5400
52 Week Low 30.1450
50-Day Moving Average 30.2093
200-Day Moving Average 30.2717

Share Statistics

Avg Vol (3 month) 3600.2k
Avg Vol (10 day) 3191.67k
Shares Outstanding 5140.18M
Implied Shares Outstanding 6N/A
Float 142.24M
% Held by Insiders 15.41%
% Held by Institutions 16.20%
Shares Short (Apr. 14, 2021) 4541.76k
Short Ratio (Apr. 14, 2021) 40.91
Short % of Float (Apr. 14, 2021) 4N/A
Short % of Shares Outstanding (Apr. 14, 2021) 40.39%
Shares Short (prior month Mar. 14, 2021) 472.36k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:2
Last Split Date 3Oct. 16, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Aug. 30, 2020
Most Recent Quarter (mrq)Feb. 27, 2021


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-88.86%
Return on Equity (ttm)-160.48%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-13.4M
Diluted EPS (ttm)-0.1050
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.04M
Total Cash Per Share (mrq)0.02
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.60
Book Value Per Share (mrq)0.06

Cash Flow Statement

Operating Cash Flow (ttm)-10.65M
Levered Free Cash Flow (ttm)-3.07M